Skip to main content

Letter - EIA Scrutiny Panel to EDTSC Minister - Medicinal Cannabis Terms of Reference - 13 April 202

The official version of this document can be found via the PDF button.

The below content has been automatically generated from the original PDF and some formatting may have been lost, therefore it should not be relied upon to extract citations or propose amendments.

States Greffe: Scrutiny

Senator Lyndon Farnham

Minister for Economic Development, Tourism, Sport and Culture

By email

13th April 2021 Dear Minister

Economic and International Affairs Scrutiny Panel

Regulations for the licensing, production and export of Medicinal Cannabis in Jersey

I write to inform you that Economic and International Affairs Scrutiny Panel has agreed to undertake a review of the Regulations for the licensing, production and export of Medicinal Cannabis in Jersey.

We intend to begin our work immediately which will run alongside our reviews of the Covid-19, Support for Small Business and our upcoming review on the work of the JCRA. Attached to this letter are the Terms of Reference.

We will be intending to hold a series of public hearings with you, the Minister for Health and Social Services and in addition, we propose to seek the views of key stakeholders.

We hope that the evidence we gather and our final Report will be beneficial and will help inform the work of your department in this area.

I would be happy to address any questions you may have about our work. Yours sincerely

Deputy David Johnson

Chair

Economic and International Affairs Scrutiny Panel

States Greffe: Scrutiny | Morier House | St Helier | Jersey | JE1 1DD Tel: 01534 441080 | email: scrutiny@gov.je | web: statesassembly.gov.je

Economic and International Affairs Scrutiny Panel Terms of Reference

Regulations for the licensing, production and export of Medicinal Cannabis in Jersey

  1. To examine and benchmark the Regulations establishing the terms of licensing for the cultivation, import and export of medicinal cannabis and the comparison with other relevant jurisdictions.
  2. To examine the merits to the Island of requiring applicants to obtain EU/Good Manufacturing Practice (GMP) certification.
  3. To evaluate the projected economic benefit to the Island of this sector, including identifying any inherent costs to the taxpayer of associated regulation and administration.
  4. To identify and evaluate the full scope of the tax regime associated with the sector.
  5. To examine any potential impact, positive or negative, on the international reputation of the Island in establishing an industry based on the cultivation, import and export of medicinal cannabis.